HUP0300770A2 - Tartrate salt of thiazolidinedione derivative - Google Patents
Tartrate salt of thiazolidinedione derivativeInfo
- Publication number
- HUP0300770A2 HUP0300770A2 HU0300770A HUP0300770A HUP0300770A2 HU P0300770 A2 HUP0300770 A2 HU P0300770A2 HU 0300770 A HU0300770 A HU 0300770A HU P0300770 A HUP0300770 A HU P0300770A HU P0300770 A2 HUP0300770 A2 HU P0300770A2
- Authority
- HU
- Hungary
- Prior art keywords
- active pharmaceutical
- tartrate salt
- thiazolidinedione derivative
- pharmaceutical ingredient
- tartrate
- Prior art date
Links
- 150000003892 tartrate salts Chemical class 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 4
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 abstract 1
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Abstract
A találmány az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-mezo-tartarátra és szolvátjaira mint újgyógyszerhatóanyagra, a gyógyszerhatóanyag előállítási eljárására, agyógyszerhatóanyagot tartalmazó gyógyszerkészítményekre, valamint agyógyszerhatóanyag gyógyászati alkalmazására vonatkozik. ÓThe invention relates to 5-[4-{2-[N-methyl-N-(2-pyridyl)-amino]-ethoxy}-benzyl]-2,4-dioxo-thiazolidine meso-tartrate and its solvates as new active pharmaceutical ingredients, refers to the production process of the active pharmaceutical ingredient, pharmaceutical preparations containing the active pharmaceutical ingredient, and the medicinal use of the active pharmaceutical ingredient. HE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0019226.0A GB0019226D0 (en) | 2000-08-04 | 2000-08-04 | Novel pharmaceutical |
| PCT/GB2001/003514 WO2002012233A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salts of thiazolidinedione derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0300770A2 true HUP0300770A2 (en) | 2003-11-28 |
Family
ID=9897028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300770A HUP0300770A2 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1307448A1 (en) |
| JP (1) | JP2004505971A (en) |
| KR (1) | KR20030022356A (en) |
| CN (1) | CN1458930A (en) |
| AP (1) | AP2003002737A0 (en) |
| AU (1) | AU2001276508A1 (en) |
| BG (1) | BG107605A (en) |
| BR (1) | BR0112984A (en) |
| CA (1) | CA2417828A1 (en) |
| CZ (1) | CZ2003314A3 (en) |
| EA (1) | EA200300231A1 (en) |
| EC (1) | ECSP034468A (en) |
| GB (1) | GB0019226D0 (en) |
| HU (1) | HUP0300770A2 (en) |
| IL (1) | IL154277A0 (en) |
| MA (1) | MA25830A1 (en) |
| MX (1) | MXPA03001086A (en) |
| NO (1) | NO20030508L (en) |
| OA (1) | OA12355A (en) |
| PL (1) | PL360702A1 (en) |
| SK (1) | SK1452003A3 (en) |
| WO (1) | WO2002012233A1 (en) |
| ZA (1) | ZA200300962B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| FR2845602B1 (en) * | 2002-10-11 | 2005-07-08 | Servier Lab | ASSOCIATION BETWEEN A LIGAND OF RECEPTORS ACTIVE BY PEROXISOME PROLIFIERS AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US7264813B2 (en) | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| CN102532122B (en) * | 2010-12-29 | 2015-12-02 | 开封制药(集团)有限公司 | The preparation method of Tartraric rosiglitazone |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-08-04 GB GBGB0019226.0A patent/GB0019226D0/en not_active Ceased
-
2001
- 2001-08-03 MX MXPA03001086A patent/MXPA03001086A/en unknown
- 2001-08-03 AP APAP/P/2003/002737A patent/AP2003002737A0/en unknown
- 2001-08-03 EP EP01954161A patent/EP1307448A1/en not_active Withdrawn
- 2001-08-03 KR KR10-2003-7001605A patent/KR20030022356A/en not_active Application Discontinuation
- 2001-08-03 CZ CZ2003314A patent/CZ2003314A3/en unknown
- 2001-08-03 HU HU0300770A patent/HUP0300770A2/en unknown
- 2001-08-03 CN CN01815682A patent/CN1458930A/en active Pending
- 2001-08-03 WO PCT/GB2001/003514 patent/WO2002012233A1/en not_active Application Discontinuation
- 2001-08-03 IL IL15427701A patent/IL154277A0/en unknown
- 2001-08-03 AU AU2001276508A patent/AU2001276508A1/en not_active Abandoned
- 2001-08-03 EA EA200300231A patent/EA200300231A1/en unknown
- 2001-08-03 BR BR0112984-8A patent/BR0112984A/en not_active IP Right Cessation
- 2001-08-03 OA OA1200300029A patent/OA12355A/en unknown
- 2001-08-03 JP JP2002518208A patent/JP2004505971A/en active Pending
- 2001-08-03 SK SK145-2003A patent/SK1452003A3/en unknown
- 2001-08-03 PL PL01360702A patent/PL360702A1/en not_active Application Discontinuation
- 2001-08-03 CA CA002417828A patent/CA2417828A1/en not_active Abandoned
-
2003
- 2003-01-31 NO NO20030508A patent/NO20030508L/en not_active Application Discontinuation
- 2003-02-03 MA MA27022A patent/MA25830A1/en unknown
- 2003-02-04 EC EC2003004468A patent/ECSP034468A/en unknown
- 2003-02-04 ZA ZA200300962A patent/ZA200300962B/en unknown
- 2003-02-28 BG BG107605A patent/BG107605A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004505971A (en) | 2004-02-26 |
| KR20030022356A (en) | 2003-03-15 |
| NO20030508D0 (en) | 2003-01-31 |
| GB0019226D0 (en) | 2000-09-27 |
| NO20030508L (en) | 2003-03-20 |
| AU2001276508A1 (en) | 2002-02-18 |
| CN1458930A (en) | 2003-11-26 |
| AP2003002737A0 (en) | 2003-03-31 |
| CA2417828A1 (en) | 2002-02-14 |
| BR0112984A (en) | 2003-06-10 |
| ECSP034468A (en) | 2003-03-31 |
| OA12355A (en) | 2004-03-19 |
| MA25830A1 (en) | 2003-07-01 |
| EP1307448A1 (en) | 2003-05-07 |
| IL154277A0 (en) | 2003-09-17 |
| EA200300231A1 (en) | 2003-06-26 |
| PL360702A1 (en) | 2004-09-20 |
| MXPA03001086A (en) | 2003-05-27 |
| CZ2003314A3 (en) | 2004-02-18 |
| ZA200300962B (en) | 2003-10-29 |
| SK1452003A3 (en) | 2004-05-04 |
| BG107605A (en) | 2003-09-30 |
| WO2002012233A1 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0204122A2 (en) | Novel composition based on a thiazolidinedione and metformin and its use | |
| HUP0302086A2 (en) | Oral pharmaceutical composition with a delayed action and process for its preparation | |
| EE05383B1 (en) | Pol arecarboxamide Compounds, Preparation and Use of Aliphatic Lowering Active Ingredients and Pharmaceutical Ingredients | |
| HUP0302131A2 (en) | Pharmaceutical tramadol salts, pharmaceutical compositions containing them | |
| HUP0301512A2 (en) | Treatment of gastrointestinal stromal tumors | |
| DK1289517T3 (en) | Pharmaceutical compositions containing cannabidiol derivatives | |
| HUP0303082A2 (en) | Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use | |
| HUP0402154A2 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
| RU2010128019A (en) | ORAL DISPERSABLE TABLET | |
| HUP0201877A2 (en) | Fast-dispersing dosage forms containing fish gelatin | |
| HUP0204202A2 (en) | Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it | |
| HUP0401605A2 (en) | Integrin inhibitors for the treatment of eye diseases | |
| HUP0301390A2 (en) | Oral pharmaceutical composition containing valsartan | |
| ID28510A (en) | NEW ORAL FORMULATION FOR AGONISTS OR 5-HT4 ANTAGONISTS | |
| DE60220055D1 (en) | 4- (4-METHOXYBENZYL) -N '- (5-NITRO-1,3-THIAZOLE-2-YL) UREA AND ITS USE IN THE TREATMENT OF GLYCOGENSYNTHASEKINASE-3 (GSK3) ASSOCIATED SUFFERING | |
| HUP0300972A2 (en) | Gatifloxacin pentahydrate | |
| HUP0001583A2 (en) | A pyridine-1-oxide derivative and process for its transformation into pharmaceutically effective compounds | |
| HUP0300777A2 (en) | Tartrate salt of thiazolidinedione derivative | |
| HUP0300770A2 (en) | Tartrate salt of thiazolidinedione derivative | |
| HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| HUP0300938A2 (en) | The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| HUP0300778A2 (en) | Tartrate sal of thiazolidinedione derivative | |
| HUP0301137A2 (en) | Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same | |
| TW200800977A (en) | A new salt | |
| HUP0300863A2 (en) | N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide, process for producing it and pharmaceutical composition containing it |